Skip to main content
Article
High Level Health Care Utilization in Severe and Difficult-to-treat Asthma [Abstract #897]
Journal of Allergy and Clinical Immunology (2002)
  • Mary Lou Hayden, Virginia Adult & Pediatric Allergy & Asthma, Richmond
  • C. Johnson, Genentech
  • Chantal M. Dolan, Genentech
  • Susan Morris, Genentech
  • Eugene R. Bleecker, Wakeforest University
Abstract
OBJECTIVE: To describe health care utilization of patients with severe or difficult-to-treat asthma.

METHODS: Over 200 pulmonologists and allergists from academic centers, private practices and health management organizations across the United States are participating in the TENOR study. Patients 6 years and older with a diagnosis of severe or difficult-to-treat asthma were surveyed for their health care utilization.
RESULTS: 2378 patients with severe or difficult-to-treat asthma were enrolled between January 2 and May 28, 2001. Table 1 includes data on health care utilization. When stratified by lung function (FEV1 60% but <80%, >_ 80% predicted), overall there were no major differences in the data presented.

CONCLUSION: In this large cohort of severe or difficult to treat patients with asthma, we observed a high level of healthcare utilization. Of specific concern is the reported high proportion of patients requiring hospitalization or emergency care in the previous 3 months. A high percentage of patients reported a history of having been intubated or on mechanical ventilation. In addition, nearly half of the subjects reported unscheduled office visits and the requirement for oral steroid therapy, reflecting poor control of their disease. It does not appear that FEV1 alone predicts healthcare utilization. These results demonstrate the impact of severe and difficult-to-treat
asthma on both patients and the health care system.
Keywords
  • asthma
Publication Date
2002
Citation Information
Mary Lou Hayden, C. Johnson, Chantal M. Dolan, Susan Morris, et al.. "High Level Health Care Utilization in Severe and Difficult-to-treat Asthma [Abstract #897]" Journal of Allergy and Clinical Immunology Vol. 109 Iss. 1, Supplement 1 (2002) p. S293 ISSN: 0091-6749
Available at: http://works.bepress.com/susan_morris/5/